PD24-06 PROSTATIC ARTERY EMBOLIZATION TO TREAT GROSS HEMATURIA ATTRIBUTABLE TO BENIGN PROSTATIC HYPERPLASIA: A SINGLE CENTER ANALYSIS OF 3-YEAR OUTCOMES

INTRODUCTION AND OBJECTIVES:Prostatic artery embolization (PAE) is a minimally invasive angiographic procedure used to treat hematuria caused by benign prostatic hyperplasia (BPH). However scarce outcomes data exist on PAE for gross hematuria. This study presents medium-term safety and efficacy data for PAE to treat gross hematuria caused by BPH.METHODS:66 patients undergoing PAE in the setting of gross hematuria from December 2013 through August 2018 were reviewed retrospectively. Patients were included if cystoscopy found a large bleeding prostate and upper tract evaluation was negative. Patients were excluded for other hematuria sources (infection, stones or cancer) (n=11). 16 patients were treated for severe hematuria (SH) requiring continuous bladder irrigation (CBI) (age 79.8±8.8, Charlson comorbidity index (CCI) 5.8±2.5, prostate gland volume (PGV) 326±171mL). 39 patients had gross hematuria (GH), but were embolized to treat urinary retention (17 patients: age 76.7±9.0, CCI 4.1±1.7, PGV 191±79mL), ...